Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BLND
BLND logo

BLND Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Blend Labs Inc (BLND) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.690
1 Day change
-1.17%
52 Week Range
4.490
Analysis Updated At
2026/06/05
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

BLND is not a good immediate buy for a Beginner long-term investor with $50,000-$100,000 available right now. The stock has supportive analyst opinions, but the repeated price target cuts, mixed ratings, and ongoing mortgage-market weakness suggest the upside is still dependent on a slow recovery. Since there is no strong proprietary buy signal today and the price trend data is unavailable, the best call is to hold off rather than buy immediately.

Technical Analysis

No stock trend data was available, so a precise price-action read is not possible. Based on the available information, there is no confirmed bullish trend or strong technical breakout signal. The market is also described as trading in line with the S&P 500 at 0% change, which does not indicate momentum. With no AI Stock Picker or SwingMax entry signal, the technical setup is not strong enough to justify an urgent buy.

Positive Catalysts

  • Canaccord also said Blend continues pushing growth, profitability, and product expansion. Longer term, a recovery in mortgage volumes could support the business.

Neutral/Negative Catalysts

  • Several firms cut price targets recently, including Goldman Sachs, Keefe Bruyette, Citizens, Canaccord, UBS, and Wells Fargo, showing tempered expectations. UBS pointed to elevated interest rates pressuring forward estimates. Citizens said Q2 guidance was disappointing. The company remains exposed to a tough mortgage macro, and no recent political or insider buying/selling data was provided to offset that.

Financial Performance

Latest quarter referenced: Q1. The company reportedly delivered strong Q1 results, but guidance for Q2 was disappointing. That suggests the recent quarter showed operational strength, yet forward growth expectations remain pressured by the mortgage environment. Overall, the latest quarter points to improving product traction but still uneven near-term revenue growth trends.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst action shows a positive but cautious tone. Canaccord, Goldman Sachs, Keefe Bruyette, Citizens, UBS, and Wells Fargo all reduced price targets, which signals softer near-term expectations. Even so, most of the named firms kept Buy, Outperform, or Overweight-type ratings. Wall Street’s pros and cons view is mixed: the bull case centers on product expansion, Autopilot monetization, and a future mortgage recovery, while the bear case focuses on rate pressure, weak guidance, and slowing growth expectations.

Wall Street analysts forecast BLND stock price to rise
5 Analyst Rating
Wall Street analysts forecast BLND stock price to rise
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 1.710
sliders
Low
3
Averages
4.19
High
5.25
Current: 1.710
sliders
Low
3
Averages
4.19
High
5.25
Canaccord
Buy
downgrade
AI Analysis
2026-05-15
Reason
Canaccord
Price Target
AI Analysis
2026-05-15
downgrade
Buy
Reason
Canaccord lowered the firm's price target on Blend Labs to $4.50 from $5.25 and keeps a Buy rating on the shares. The firm said Blend continues to do all it can in terms of growth, profitability, and product set expansion, despite the persistently tough mortgage macro.
Goldman Sachs
Buy
downgrade
$4
2026-05-08
Reason
Goldman Sachs
Price Target
$4
2026-05-08
downgrade
Buy
Reason
Goldman Sachs lowered the firm's price target on Blend Labs to $3.50 from $4 and keeps a Buy rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for BLND
Unlock Now

People Also Watch